SCHEMBL6513237

SCHEMBL6513237

COc1ccc(S(=O)(=O)Nc2ccc3sc(C(=O)NO)cc3c2)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.65
MEN1 O00255 1/20 0.65
KMT2A Q03164 1/20 0.65
HDAC1 Q13547 7/20 0.60
HDAC4 P56524 3/20 0.54
HDAC3 O15379 2/20 0.54
HDAC7 Q8WUI4 2/20 0.54
HDAC2 Q92769 2/20 0.54
HDAC10 Q969S8 2/20 0.54
HDAC11 Q96DB2 2/20 0.54
HDAC8 Q9BY41 2/20 0.54
HDAC6 Q9UBN7 2/20 0.54
HDAC9 Q9UKV0 2/20 0.54
HDAC5 Q9UQL6 2/20 0.54
CYP19A1 P11511 1/20 0.52
PKM P14618 1/20 0.52
ALDH1A1 P00352 1/20 0.51
FFAR4 Q5NUL3 1/20 0.51
PLAU P00749 1/20 0.50
POLB P06746 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1888015 0.87 MAPT (0.77) MAPTMEN1KMT2AHDAC1HDAC4
SCHEMBL6512630 0.87 HDAC1 (0.63) MAPTMEN1KMT2AHDAC1HDAC4
SCHEMBL6510493 0.87 HDAC1 (0.67) MAPTMEN1KMT2AHDAC1FFAR4
SCHEMBL6508051 0.87 MEN1 (0.60) MAPTMEN1KMT2AHDAC1HDAC4
SCHEMBL6508074 0.85 HDAC1 (0.63) MAPTMEN1KMT2AHDAC1HDAC4
SCHEMBL1889670 0.84 HDAC1 (0.81) MAPTMEN1KMT2AHDAC1HDAC4
SCHEMBL1883718 0.84 HDAC1 (0.69) MAPTMEN1KMT2AHDAC1HDAC4
SCHEMBL1892313 0.83 HDAC1 (0.71) MAPTMEN1KMT2AHDAC1HDAC4
SCHEMBL6508477 0.80 HDAC1 (0.71) MEN1KMT2AHDAC1HDAC6PKM
SCHEMBL6508072 0.80 HDAC1 (0.63) MAPTMEN1KMT2AHDAC1HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005066151-A2 HISTONE DEACETYLASE INHIBITORS TAKEDA SAN DIEGO, INC. (US) 2005-07-21 WO claimed
US-20050137234-A1 Histone deacetylase inhibitors SYRRX, INC. 2005-06-23 US claimed
US-20050137234-A1 Histone deacetylase inhibitors SYRRX, INC. 2005-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050137234-A1 Histone deacetylase inhibitors HDAC1, HDAC5, HDAC11 MAPT 2607/4885MEN1 2925/4885KMT2A 45/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.